Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Pregnancy and Childbirth
Published in: BMC Pregnancy and Childbirth 1/2020

Open Access 01-12-2020 | Opioids | Research article

In their own words: a qualitative study of factors promoting resilience and recovery among postpartum women with opioid use disorders

Authors: Daisy J. Goodman, Elizabeth C. Saunders, Kristina B. Wolff

Published in: BMC Pregnancy and Childbirth | Issue 1/2020

Login to get access

Abstract

Background

Opioid use disorder (OUD) is associated with substantial morbidity and mortality for women, especially during the perinatal period. Opioid overdose has become a significant cause of maternal death in the United States, with rates highest in the immediate postpartum year. While pregnancy is a time of high motivation for healthcare engagement, unique challenges exist for pregnant women with OUD seeking both substance use treatment and maternity care, including managing change after birth. How women successfully navigate these barriers, engage in treatment, and abstain from substance use during pregnancy and postpartum is poorly understood. The aim of this study is to explore the experiences of postpartum women with OUD who successfully engaged in both substance use treatment and maternity care during pregnancy, to understand factors contributing to their ability to access care and social support.

Methods

We conducted semi-structured, in-depth interviews with postpartum women in sustained recovery (n = 10) engaged in a substance use treatment program in northern New England. Interviews were analyzed using grounded theory methodology.

Results

Despite multiple barriers, women identified pregnancy as a change point from which they were able to develop self-efficacy and exercise agency in seeking care. A shift in internal motivation enabled women to disclose need for OUD treatment to maternity care providers, a profoundly significant moment. Concurrently, women developed a new capacity for self-care, demonstrated through managing relationships with providers and family members, and overcoming logistical challenges which had previously seemed overwhelming. This transformation was also expressed in making decisions based on pregnancy risk, engaging with and caring for others, and providing peer support. Women developed resilience through the interaction of inner motivation and their ability to positively utilize or transform external factors.

Conclusions

Complex interactions occurred between individual-level changes in treatment motivation due to pregnancy, emerging self-efficacy in accessing resources, and engagement with clinicians and peers. This transformative process was identified by women as a key factor in entering recovery during pregnancy and sustaining it postpartum. Clinicians and policymakers should target the provision of services which promote resilience in pregnant women with OUD.
Appendix
Available only for authorised users
Literature
1.
Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2017 National Survey on drug use and health: detailed tables. Rockville: Department of Health and Human Services; 2018.
2.
Office on Women’s Health. Opioid use, misuse, and overdose in women. Washinton, D.C: U.S. Department of Health and Human Services; 2016.
3.
Maeda A, Bateman BT, Clancy CR, Creanga AA, Leffert LR. Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes. Anesthesiology. 2014;121(6):1158–65.PubMedCrossRef
4.
Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM. Opioid use disorder documented at delivery hospitalization - United States, 1999-2014. Morb Mortal Wkly Rep. 2018;67(31):845–9.CrossRef
5.
Metz TD, Rovner P, Hoffman MC, Allshouse AA, Beckwith KM, Binswanger IA. Maternal deaths from suicide and overdose in Colorado, 2004-2012. Obstet Gynecol. 2016;128(6):1233–40.PubMedPubMedCentralCrossRef
6.
Schiff DM, Nielsen T, Terplan M, Hood M, Bernson D, Diop H, et al. Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts. Obstet Gynecol. 2018;132(2):466–74.PubMedPubMedCentralCrossRef
7.
Substance Abuse and Mental Health Services Administration (SAMHSA). Clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants. Rockville: US Department of Health and Human Services; 2018. Contract No.: HHS Publication No. (SMA) 18–5054.
8.
American College of Obstetricians and Gynecologists (ACOG), American Society of Addiction Medicine (ASAM). Opioid use and opioid use disorder in pregnancy: Committee opinion No. 711. Obstet Gynecol. 2017;130:e81–94.CrossRef
9.
Reddy UM, Davis JM, Ren Z, Greene MF. Opioid use in pregnancy, neonatal abstinence syndrome, and childhood outcomes: executive summary of a joint workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation. Obstet Gynecol. 2017;130(1):10–28.PubMedPubMedCentralCrossRef
10.
World Health Organization (WHO). Guidelines for identification and management of substance use disorders in pregnancy. Geneva: CH; 2014.
11.
Alliance for Innovation on Maternal Health (AIM). Obstetric care for women with opioid use disorder. Washington, D.C: American College of Obstetricians and Gynecologists (ACOG); 2017.
12.
Wilder C, Lewis D, Winhusen T. Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder. Drug Alcohol Depend. 2015;149:225–31.PubMedCrossRef
13.
Terplan M, Kennedy-Hendricks A, Chisolm MS. Prenatal substance use: exploring assumptions of maternal unfitness. Subst Abus. 2015;9(Suppl 2):1–4.
14.
Oberman M. Sex, drugs, pregnancy, and the law: rethinking the problems of pregnant women who use drugs. Hastings Law J. 1992;43(3):505–48.PubMed
15.
Inciardi JA, Lockwood D, Pottiger AE. Women and crack-cocaine. Macmillian: Toronto; 1993.
16.
Roberts SC, Pies C. Complex calculations: how drug use during pregnancy becomes a barrier to prenatal care. Matern Child Health J. 2011;15(3):333–41.PubMedCrossRef
17.
Howard H. Experiences of opioid-dependent women in their prenatal and postpartum care: implications for social workers in health care. Soc Work Health Care. 2016;55(1):61–85.PubMedCrossRef
18.
Stringer KL, Baker EH. Stigma as a barrier to substance abuse treatment among those with unmet need: an analysis of parenthood and marital status. J Fam Issues. 2018;39(1):3–27.PubMedCrossRef
19.
Taylor OD. Barriers to treatment for women with substance use disorders. J Hum Behav Soc Environ. 2010;20(3):393–409.CrossRef
20.
21.
22.
23.
Jackson A, Shannon L. Barriers to receiving substance abuse treatment among rural pregnant women in Kentucky. Matern Child Health J. 2012;16(9):1762–70.PubMedCrossRef
24.
Appel PW, Ellison AA, Jansky HK, Oldak R. Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders. Am J Drug Alcohol Abuse. 2004;30(1):129–53.PubMedCrossRef
25.
Copeland J. A qualitative study of barriers to formal treatment among women who self-managed change in addictive behaviours. J Subst Abus Treat. 1997;14(2):183–90.CrossRef
26.
Denton WH, Adinoff BH, Lewis D, Walker R, Winhusen T. Family discord is associated with increased substance use for pregnant substance users. Subst Use Misuse. 2014;49(3):326–32.PubMedCrossRef
27.
Greenfield SF, Brooks AJ, Gordon SM, Green CA, Kropp F, McHugh RK, et al. Substance abuse treatment entry, retention, and outcome in women: a review of the literature. Drug Alcohol Depend. 2007;86(1):1–21.PubMedCrossRef
28.
Haller DL, Knisely JS, Elswick RK Jr, Dawson KS, Schnoll SH. Perinatal substance abusers: factors influencing treatment retention. J Subst Abus Treat. 1997;14(6):513–9.CrossRef
29.
Schempf AH, Strobino DM. Drug use and limited prenatal care: An examination of responsible barriers. Am J Obstet Gynecol. 2009;200(4):412.e1–10.CrossRef
30.
Shahram SZ, Bottorff JL, Oelke ND, Kurtz DL, Thomas V, Spittal PM, et al. Mapping the social determinants of substance use for pregnant-involved young aboriginal women. Int J Qual Stud Health Well Being. 2017;12(1):1275155.PubMedPubMedCentralCrossRef
31.
Stajduhar KI, Funk L, Shaw AL, Bottorff JL, Johnson J. Resilience from the perspective of the illicit injection drug user: an exploratory descriptive study. Int J Drug Policy. 2009;20(4):309–16.PubMedCrossRef
32.
Rudzinski K, McDonough P, Gartner R, Strike C. Is there room for resilience? A scoping review and critique of substance use literature and its utilization of the concept of resilience. Subst Abuse Treat Prev Policy. 2017;12(1):41.PubMedPubMedCentralCrossRef
33.
Windle G. What is resilience? A review and concept analysis. Rev Clin Gerontol. 2011;21(2):152–69.CrossRef
34.
Herrman H, Stewart DE, Diaz-Granados N, Berger EL, Jackson B, Yuen T. What is resilience? Can J Psychiatr. 2011;56(5):258–65.CrossRef
35.
36.
37.
Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths: United States, 2000-2014. Morb Mortal Wkly Rep. 2016;64(50–51):1378–82.CrossRef
38.
Centers for Disease Control and Prevention (CDC). Drug overdose death data. Atlanta: U.S. Department of Health and Human Services; 2017.
39.
O'Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden RM. Deaths involving fentanyl, fentanyl analogs, and U-47700 - 10 states, July-December 2016. Morb Mortal Wkly Rep. 2017;66(43):1197–202.CrossRef
40.
Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B, et al. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018;52(4):1893–907.PubMedCrossRef
41.
42.
Glaser B, Strauss A. The discovery of grounded theory; strategies for qualitative research. Chicago: Aldine Pub. Co.; 1967.
43.
Charmaz K. Constructing grounded theory: a practical guide through qualitative analysis. London: SAGE Publications Ltd.; 2006.
44.
Boeije H. A purposeful approach to the constant comparative method in the analysis of qualitative interviews. Qual Quant. 2002;36:391–409.CrossRef
45.
Daley M, Argeriou M, McCarty D. Substance abuse treatment for pregnant women: a window of opportunity? Addict Behav. 1998;23(2):239–49.PubMedCrossRef
46.
Gjesfjeld CD, Weaver AC, Schommer K. Rural women's transitions to motherhood: understanding social support in a rural community. J Fam Soc Work. 2012;15(5):435–48.CrossRef
47.
Ondersma SJ, Winhusen T, Lewis DF. External pressure, motivation, and treatment outcome among pregnant substance-using women. Drug Alcohol Depend. 2010;107(2–3):149–53.PubMedCrossRef
48.
Saleebey D. The strengths approach to practice. In: Saleebey D, editor. The strengths perspective in social work practice. Boston: Pearson/Allyn and Bacon; 2006. p. 77–92.
49.
Karoll BR. Applying social work approaches, harm reduction and practice wisdom to better serve those with alcohol and drug use disorders. J Soc Work. 2010;10(3):263–81.CrossRef
50.
51.
Kroll-Desrosiers AR, Crawford SL, Moore Simas TA, Rosen AK, Mattocks KM. Improving pregnancy outcomes through maternity care coordination: a systematic review. Womens Health Issues. 2016;26(1):87–99.PubMedCrossRef
52.
Larson A, Berger LM, Mallinson DC, Grodsky E, Ehrenthal DB. Variable uptake of Medicaid-covered prenatal care coordination: the relevance of treatment level and service context. J Community Health. 2019;44(1):32–43.PubMedPubMedCentralCrossRef
53.
54.
Metadata
Title
In their own words: a qualitative study of factors promoting resilience and recovery among postpartum women with opioid use disorders
Authors
Daisy J. Goodman
Elizabeth C. Saunders
Kristina B. Wolff
Publication date
01-12-2020
Publisher
BioMed Central
Keywords
Opioids
Opioids
Published in
BMC Pregnancy and Childbirth / Issue 1/2020
Electronic ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-020-02872-5

Other articles of this Issue 1/2020

BMC Pregnancy and Childbirth 1/2020 Go to the issue

Research article

Prenatal screening in the era of non-invasive prenatal testing: a Nationwide cross-sectional survey of obstetrician knowledge, attitudes and clinical practice

Research article

Women’s characteristics and care outcomes of caseload midwifery care in the Netherlands: a retrospective cohort study

Research article

Well-being in high-risk pregnancy: an integrative review

Research article

Impact of some social and clinical factors on the development of postpartum depression in Chinese women

Research article

Is it home delivery or health facility? Community perceptions on place of childbirth in rural Northwest Tanzania using a qualitative approach

Research article

Association between vitamin D plasma concentrations and VDR gene variants and the risk of premature birth